1. Living with respiratory viruses: The next saga in human/viral coexistence?
- Author
-
Ruaño, Gualberto and Ha, Toan
- Subjects
medicine.medical_specialty ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,viruses ,Personalized treatment ,antiviral treatment ,Asymptomatic ,General Biochemistry, Genetics and Molecular Biology ,SARS‐CoV‐2 ,03 medical and health sciences ,0302 clinical medicine ,COVID-19 Testing ,COVID‐19 ,respiratory viruses ,Epidemiology ,Influenza, Human ,differential diagnosis ,medicine ,Humans ,epidemiological screening ,Respiratory system ,Pathogen ,Asymptomatic Infections ,Respiratory Tract Infections ,Thoughts & Opinion ,030304 developmental biology ,0303 health sciences ,Ex Laboratorio ,Host Microbial Interactions ,business.industry ,SARS-CoV-2 ,COVID-19 ,multi‐viral testing ,Virology ,Antibodies, Neutralizing ,Carrier State ,Quarantine ,Carrier status ,Respiratory virus ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Testing for respiratory viruses and SARS-CoV-2 in clinical and epidemiological settings has contrasting purposes and utility. Symptomatic patients are best tested with respiratory virus panels to establish the pathogen and guide personalized treatment. Asymptomatic patients are tested for a single infectious pathogen to establish carrier status and guide containment.
- Published
- 2020